• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Should the new EASL-EASD-EASO Clinical Practice Guidelines on MASLD recommend pioglitazone as a MASH-targeted pharmacotherapy?

作者信息

Silva Júnior Wellington S, Sposito Andrei C, Godoy-Matos Amélio

机构信息

Universidade Federal do Maranhão (UFMA), Sao Luis, MA, Brazil.

Universidade Estadual de Campinas (Unicamp), Campinas, SP, Brazil.

出版信息

J Hepatol. 2025 Jan;82(1):e21-e22. doi: 10.1016/j.jhep.2024.06.034. Epub 2024 Jul 4.

DOI:10.1016/j.jhep.2024.06.034
PMID:38971532
Abstract
摘要

相似文献

1
Should the new EASL-EASD-EASO Clinical Practice Guidelines on MASLD recommend pioglitazone as a MASH-targeted pharmacotherapy?新版欧洲肝脏研究学会（EASL）-欧洲糖尿病研究学会（EASD）-欧洲肥胖症研究学会（EASO）非酒精性脂肪性肝病（MAFLD）临床实践指南是否应推荐吡格列酮作为针对MAFLD的药物治疗？
J Hepatol. 2025 Jan;82(1):e21-e22. doi: 10.1016/j.jhep.2024.06.034. Epub 2024 Jul 4.
2
EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary.EASL-EASD-EASO 临床实践指南：代谢功能障碍相关脂肪性肝病（MASLD）的管理。执行摘要。
Diabetologia. 2024 Nov;67(11):2375-2392. doi: 10.1007/s00125-024-06196-3.
3
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).EASL-EASD-EASO 临床实践指南：代谢功能障碍相关脂肪性肝病（MASLD）的管理。
Obes Facts. 2024;17(4):374-444. doi: 10.1159/000539371. Epub 2024 Jun 7.
4
EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).EASL-EASD-EASO 临床实践指南：代谢功能障碍相关脂肪性肝病（MASLD）的管理。
J Hepatol. 2024 Sep;81(3):492-542. doi: 10.1016/j.jhep.2024.04.031. Epub 2024 Jun 7.
5
EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: do they lead to over-referral?EASL-EASD-EASO 临床实践指南：严重肥胖人群非酒精性脂肪性肝病的管理——是否导致过度转诊？
Diabetologia. 2017 Jul;60(7):1218-1222. doi: 10.1007/s00125-017-4264-9. Epub 2017 Mar 28.
6
Publisher Correction: EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary.出版商更正：欧洲肝脏研究学会（EASL）-欧洲糖尿病研究学会（EASD）-欧洲肥胖症研究学会（EASO）代谢功能障碍相关脂肪性肝病（MASLD）管理临床实践指南：执行摘要。
Diabetologia. 2024 Nov;67(11):2608. doi: 10.1007/s00125-024-06258-6.
7
Potential issues with implementation of EASL-EASD-EASO guidelines on management of MASLD in patients with type 2 diabetes in Sweden.瑞典实施欧洲肝脏研究学会（EASL）、欧洲糖尿病研究学会（EASD）和欧洲肥胖症研究学会（EASO）关于2型糖尿病患者MAFLD管理指南的潜在问题。
J Hepatol. 2025 Aug;83(2):e95-e97. doi: 10.1016/j.jhep.2025.02.018. Epub 2025 Feb 19.
8
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: is universal screening appropriate?欧洲肝脏研究学会-欧洲糖尿病研究学会-欧洲肥胖症研究学会非酒精性脂肪性肝病管理临床实践指南：普遍筛查是否合适？
Diabetologia. 2016 Jun;59(6):1141-4. doi: 10.1007/s00125-016-3910-y. Epub 2016 Apr 7.
9
EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease.欧洲肝脏研究学会（EASL）-欧洲糖尿病研究学会（EASD）-欧洲肥胖症研究学会（EASO）非酒精性脂肪性肝病管理临床实践指南
Obes Facts. 2016;9(2):65-90. doi: 10.1159/000443344. Epub 2016 Apr 8.
10
Comment to: "EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease".对《欧洲肝脏研究学会-欧洲糖尿病研究学会-欧洲肥胖研究学会非酒精性脂肪性肝病管理临床实践指南》的评论
J Hepatol. 2017 Feb;66(2):465-466. doi: 10.1016/j.jhep.2016.10.036. Epub 2016 Nov 14.

引用本文的文献

1
Highlights of the Most Recent American Diabetes Association Guidelines: From Evidence to Practice.美国糖尿病协会最新指南要点：从证据到实践
Endocrinol Metab (Seoul). 2025 Feb;40(1):67-69. doi: 10.3803/EnM.2025.2329. Epub 2025 Feb 24.